Tariffs Won’t Secure Our Drug Supply Chain—They’ll Break It
“Imposing Section 232 tariffs on medicines would worsen shortages, drive up prices, and leave patients with fewer options,” writes Pipes. getty The Trump administration is considering massive “Section 232” tariffs on imported medicines from key U.S. allies, including the European Union, the United Kingdom, Switzerland, Japan, and South Korea. While tariffs on some countries, such…